rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2009-11-25
|
pubmed:abstractText |
Microplasmin is a recombinant truncated form of human plasmin. It has demonstrated efficacy in experimental animal models of stroke and tolerability in healthy volunteers. We tested the tolerability of microplasmin in patients with acute ischemic stroke.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1524-4628
|
pubmed:author |
pubmed-author:AichnerFranzF,
pubmed-author:DavalosAntoniA,
pubmed-author:Neumann-HaefelinTobiasT,
pubmed-author:PeetersAndreA,
pubmed-author:RötherJoachimJ,
pubmed-author:SchellingerPeter DPD,
pubmed-author:SchneiderDietmarD,
pubmed-author:ThijsVincent N SVN,
pubmed-author:VerhammePeterP,
pubmed-author:VoskoMilanM,
pubmed-author:WahlgrenNilsN
|
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3789-95
|
pubmed:meshHeading |
pubmed-meshheading:19834019-Acute Disease,
pubmed-meshheading:19834019-Aged,
pubmed-meshheading:19834019-Aged, 80 and over,
pubmed-meshheading:19834019-Brain Ischemia,
pubmed-meshheading:19834019-Cerebral Revascularization,
pubmed-meshheading:19834019-Dose-Response Relationship, Drug,
pubmed-meshheading:19834019-Female,
pubmed-meshheading:19834019-Fibrinolysin,
pubmed-meshheading:19834019-Fibrinolytic Agents,
pubmed-meshheading:19834019-Humans,
pubmed-meshheading:19834019-Injections, Intravenous,
pubmed-meshheading:19834019-Magnetic Resonance Imaging,
pubmed-meshheading:19834019-Male,
pubmed-meshheading:19834019-Middle Aged,
pubmed-meshheading:19834019-Peptide Fragments,
pubmed-meshheading:19834019-Placebos,
pubmed-meshheading:19834019-Stroke,
pubmed-meshheading:19834019-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Randomized, placebo-controlled, dose-ranging clinical trial of intravenous microplasmin in patients with acute ischemic stroke.
|
pubmed:affiliation |
Department of Neurology, University Hospitals Leuven, Leuven, Belgium. vincent.thijs@uz.kuleuven.ac.be
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|